Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Wuhan General Group Updates on University of Pretoria Research Collaboration for Psilocybin Magic Mushroom Clinical Trials

Wuhan General Group Updates on University of Pretoria Research Collaboration for Psilocybin Magic Mushroom Clinical Trials

  • Post published:October 29, 2020
  • Post category:Press Release
Read more about the article Wuhan General Group Signs MOA for the Acquisition of Tsime Pharmaceuticals (PTY) Limited

Wuhan General Group Signs MOA for the Acquisition of Tsime Pharmaceuticals (PTY) Limited

  • Post published:July 17, 2020
  • Post category:Press Release
Read more about the article Wuhan General Group Signs Manufacturing, Distribution and Sales Agreement with Cafféluxe

Wuhan General Group Signs Manufacturing, Distribution and Sales Agreement with Cafféluxe

  • Post published:June 24, 2020
  • Post category:Press Release
Read more about the article Wuhan General Group Announces Name Change and Rebranding to M2Bio Sciences

Wuhan General Group Announces Name Change and Rebranding to M2Bio Sciences

  • Post published:June 18, 2020
  • Post category:Press Release
Read more about the article Wuhan General Group Signs Distribution Agreement with Medigrow for International Distribution Rights of Medical Cannabis Products

Wuhan General Group Signs Distribution Agreement with Medigrow for International Distribution Rights of Medical Cannabis Products

  • Post published:June 10, 2020
  • Post category:Press Release
Read more about the article CEO of Wuhan General Group Provides Key Updates and Outlook

CEO of Wuhan General Group Provides Key Updates and Outlook

  • Post published:May 22, 2020
  • Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More